Zileuton, an arachidonate 5-lipoxygenase (ALOX5) inhibitor, is able to reduce the invasiveness and metastasis of pancreatic cancer, where increased ALOX5 activity has been observed [78]. Here, ALOX5 is linked to pancreatic neoplasm.